BUFFALO, N.Y. -- Sankyo Pharma of Edison, N.J., a division of
Sankyo Pharma Inc., has given $100,000 to the School of Pharmacy
and Pharmaceutical Sciences at the University at Buffalo to support
its teaching, training and research, as well as for equipment
purchases in the Department of Pharmaceutical Sciences.
Wayne K. Anderson, Ph.D., dean of the school, thanked Sankyo
Pharma for its generosity and the recognition it represents.
"It is essential that the school remain at a 'state-of-the-art'
level in order for our students to develop to their fullest
potential and for the school's research programs to continue in its
leadership role," Anderson said.
William J. Jusko, Ph.D., professor and chair of the Department
of Pharmaceutical Sciences, praised the efforts of Daniel E.
Salazar, senior director of clinical pharmacology and
pharmacokinetics for Sankyo Pharma Development, who was
instrumental in securing the grant for UB. Salazar received his
doctorate from the UB School of Pharmacy and Pharmaceutical
Sciences in 1989.
Noting that some of the funding will help establish a new
computer classroom, Jusko said that "another portion will go toward
purchase of new analytical equipment, which will augment our
research in pharmacogenomics."
Pharmacogenomics is the study of how data generated by the
human-genome project can be used to tailor drug treatments to an
individual's genetic makeup.
Salazar said Sankyo Pharma places great value on pharmaceutical
sciences, and chose UB to receive the grant because of its emphasis
on education and research in this area.
"The program at the University at Buffalo is clearly excellent
and we wanted to provide support in recognition of that
excellence," Salazar said.
Sankyo Pharma is dedicated to developing and marketing important
pharmaceutical products for the U.S. market and has offices in New
Jersey and California. Its parent company, Sankyo Co., Ltd., is the
second-largest pharmaceutical company in Japan, with annual sales
of $4.5 billion and more than 11,000 employees worldwide. The
company has a long history of discovering new classes of drugs,
including breakthrough therapies for the treatment of
cardiovascular conditions, metabolic disorders/diabetes, infection
A leader in the field of pharmaceuticals for more than 100
years, Sankyo was the first modern manufacturer of Western
medicines in Japan. In 1899, it was the first company to isolate
epinephrine (also known as adrenaline), and in 1910, it identified
vitamin B1 for the first time.
The UB School of Pharmacy and Pharmaceutical Sciences ranks
fourth in the U.S. in National Institutes of Health research
funding per Ph.D. faculty member, according to the latest report on
pharmacy faculty from the American Association of Colleges of
Pharmacy. Founded in 1886, the school is the second-oldest
component of the University at Buffalo and the only pharmacy school
in the State University of New York (SUNY) system.